Latest Product Development News

Orbital UAV secures $3 million through a share placement to boost manufacturing capabilities and expand business development amid new US drone market opportunities.

Beonic Ltd has raised a total of $4.18 million through convertible notes to fund product innovation, repay debt, and advance its North African Airport Project. Major shareholders and directors are backing the raise, subject to shareholder approval.

Tinybeans Group Ltd reported a significant reduction in losses and a 12% rise in subscription revenue for FY25, driven by a strategic pivot away from advertising. The company’s restructuring efforts have improved cash flow and positioned it for sustainable growth.

Megaport Limited delivered a robust FY25 with 20% growth in annual recurring revenue and EBITDA surpassing guidance, setting the stage for continued expansion in FY26.

Mitchell Services reported a transitional FY25 with revenue growth but earnings pressure from lower utilisation and mobilisation costs. The company secured key contracts and launched a decarbonisation joint venture, positioning for a stronger FY26.

Capral Limited reported half-year earnings in line with expectations despite a 7% decline in volume, buoyed by higher aluminium prices and disciplined cost management. The company anticipates a residential market rebound in the second half of 2025 amid ongoing industrial softness.

QuickFee Limited posted a 25% increase in revenue to A$25.3 million for FY25, driven by strong growth in both Australia and the US, alongside a positive underlying EBTDA of A$2.4 million before a one-off credit loss provision.

Capral Limited reported a solid first half of 2025 with revenue growth despite volume declines, underpinned by higher aluminium prices and a robust balance sheet. The company is advancing its footprint through acquisition and share buy-back initiatives amid cautious market conditions.

VEEM Ltd reported a 15% revenue decline in FY25 amid rising costs and COVID impacts but showed a robust second-half recovery and secured a significant $65 million defence contract renewal.

VEEM Ltd posted a 15% revenue decline and a 57% net profit drop for FY25, reflecting cyclical defence contract impacts. The company secured a $65 million ASC contract extension and continues investing in R&D and automation to drive future growth.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.